Calliditas: Japan is an interesting opportunity - Redeye

Adding Viatris as a partner for Japan is interesting. The IgAN prevalence is high and the extensive use of regular health checks including urinalysis results in early discovery and a relatively large IgAN population. This is good news even if Calliditas is expected to secure a partner for Japan.

Länk till analysen i sin helhet: https://www.redeye.se/research/868560/calliditas-japan-is-an-interesting-opportunity?utm_source=finwire&utm_medium=RSS